A

AmacaThera

15 employees

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
BioTech
biotechnology
hydrogel
Therapeutics
Biopharma
pain relief

Date founded

2016

Funding rounds raised

Total raised

$10M

from 14 investors over 14 rounds

A

AmacaThera raised $10M on February 22, 2021

Investors: MaRS Investment Accelerator Fund, StandUp Ventures, Viva BioInnovator, Inveready, Sprout BioVentures, Lumira Ventures and MBX Capital

A

AmacaThera raised $2.7M on October 3, 2019

Investors: Lumira Ventures, Viva BioInnovator, Grey Sky Venture Partners and Sprout BioVentures

A

AmacaThera raised undisclosed on January 1, 2016

Investors: Ontario Bioscience Innovation Organization and Creative Destruction Lab

A

AmacaThera raised undisclosed on January 1, 2015

Investors: UTEST, University of Toronto

FAQ